Sam Ellis

Sam Ellis is an experienced executive in the life sciences and instrumentation sectors, currently serving as Chief Executive Officer at Thomson Instrument Company since October 2023. Prior to this role, Sam held the position of Vice President at Thomson Instrument from April 1999 to October 2023. Additionally, Sam was the Chief Executive Officer and Chairman of the Board at January Therapeutics from March 2020 to September 2022, and served as an Investor at Life Science Angels from November 2018 to September 2022. Academic credentials include a Bachelor's degree in Biochemistry and Molecular Biology from UC San Diego, completed in 1999.